Your browser doesn't support javascript.
loading
Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population.
Zanovello, Matteo; Ibáñez, Kristina; Brown, Anna-Leigh; Sivakumar, Prasanth; Bombaci, Alessandro; Santos, Liana; van Vugt, Joke J F A; Narzisi, Giuseppe; Karra, Ramita; Scholz, Sonja W; Ding, Jinhui; Gibbs, J Raphael; Chiò, Adriano; Dalgard, Clifton; Weisburd, Ben; Hanna, Michael G; Greensmith, Linda; Phatnani, Hemali; Veldink, Jan H; Traynor, Bryan J; Polke, James; Houlden, Henry; Fratta, Pietro; Tucci, Arianna.
Afiliación
  • Zanovello M; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Ibáñez K; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  • Brown AL; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Sivakumar P; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Bombaci A; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Santos L; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin 10126, Italy.
  • van Vugt JJFA; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK.
  • Narzisi G; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.
  • Karra R; Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
  • Scholz SW; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Ding J; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
  • Gibbs JR; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
  • Chiò A; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • Dalgard C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Weisburd B; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Hanna MG; Department of Anatomy, Physiology and Genetics, School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Greensmith L; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MT 02142, USA.
  • Veldink JH; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Traynor BJ; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK.
  • Polke J; Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, NY 10013, USA.
  • Houlden H; Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.
  • Fratta P; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
  • Tucci A; Department of Neurology, Brain Sciences Institute, Baltimore, MD 21287, USA.
Brain ; 146(7): 2723-2729, 2023 07 03.
Article en En | MEDLINE | ID: mdl-36797998
ABSTRACT
CAG repeat expansions in exon 1 of the AR gene on the X chromosome cause spinal and bulbar muscular atrophy, a male-specific progressive neuromuscular disorder associated with a variety of extra-neurological symptoms. The disease has a reported male prevalence of approximately 130 000 or less, but the AR repeat expansion frequency is unknown. We established a pipeline, which combines the use of the ExpansionHunter tool and visual validation, to detect AR CAG expansion on whole-genome sequencing data, benchmarked it to fragment PCR sizing, and applied it to 74 277 unrelated individuals from four large cohorts. Our pipeline showed sensitivity of 100% [95% confidence interval (CI) 90.8-100%], specificity of 99% (95% CI 94.2-99.7%), and a positive predictive value of 97.4% (95% CI 84.4-99.6%). We found the mutation frequency to be 13182 (95% CI 12309-14386, n = 117 734) X chromosomes-10 times more frequent than the reported disease prevalence. Modelling using the novel mutation frequency led to estimate disease prevalence of 16887 males, more than four times more frequent than the reported disease prevalence. This discrepancy is possibly due to underdiagnosis of this neuromuscular condition, reduced penetrance, and/or pleomorphic clinical manifestations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Atrofia Muscular Espinal / Receptores Androgénicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Brain Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Atrofia Muscular Espinal / Receptores Androgénicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Brain Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido